An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen

Molecular Therapy: Nucleic Acids · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles